Naftopidil

This classification denotes an antiplatelet agent and alpha-adrenergic blocking agent with the molecular formula C24H28N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R9PHW59SFN, chemically known as 1-pioerazineethanol, 4-(2-methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)- but generally known as naftopidil, which bears US NIH Compound Identifier 4418. European Medicines Agency schedules Naftopidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09132MIG. The term NAFTOPIDIL is an International Non-Proprietary Name. NAFTOPIDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule naftopidil under HS 29335995 and SITC 51576. As of Q4 2014, NAFTOPIDIL remains the US FDA Preferred Term for this commodity. Naftopidil bears US NLM identifiers UMLS ID C0083701 and NCI Concept Code C72927. SMILES: OC(CN1CCN(CC1)C1C(OC)CCCC1)COC1C2C(CCC1)CCCC2.